Janus Henderson Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $842K | Sell |
19,308
-751,274
| -97% | -$32.8M | ﹤0.01% | 1695 |
|
|
2025
Q1 | $22.8M | Buy |
770,582
+393,198
| +104% | +$11.6M | 0.01% | 540 |
|
|
2024
Q4 | $15.2M | Buy |
377,384
+362,276
| +2,398% | +$14.6M | 0.01% | 644 |
|
|
2024
Q3 | $714K | Sell |
15,108
-3,700
| -20% | -$175K | ﹤0.01% | 1848 |
|
|
2024
Q2 | $561K | Sell |
18,808
-267
| -1% | -$7.97K | ﹤0.01% | 1934 |
|
|
2024
Q1 | $766K | Buy |
19,075
+19
| +0.1% | +$763 | ﹤0.01% | 1797 |
|
|
2023
Q4 | $485K | Sell |
19,056
-35
| -0.2% | -$891 | ﹤0.01% | 2002 |
|
|
2023
Q3 | $265K | Buy |
19,091
+21
| +0.1% | +$292 | ﹤0.01% | 2248 |
|
|
2023
Q2 | $438K | Buy |
19,070
+12
| +0.1% | +$276 | ﹤0.01% | 2053 |
|
|
2023
Q1 | $565K | Buy |
+19,058
| New | +$565K | ﹤0.01% | 1942 |
|
|
2022
Q2 | – | Sell |
-5,588
| Closed | -$236K | – | 2640 |
|
|
2022
Q1 | $236K | Buy |
5,588
+4
| +0.1% | +$169 | ﹤0.01% | 2361 |
|
|
2021
Q4 | $355K | Buy |
+5,584
| New | +$355K | ﹤0.01% | 2109 |
|
|
2021
Q2 | – | Sell |
-397,708
| Closed | -$15.5M | – | 1641 |
|
|
2021
Q1 | $15.5M | Buy |
+397,708
| New | +$15.5M | 0.01% | 831 |
|